کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
3064189 | 1580407 | 2014 | 12 صفحه PDF | دانلود رایگان |
• p65/RelA and p65/RelA-regulated genes were analyzed in Huntington's disease (HD).
• CB1, IL-1β, IL-8, CCL5, GM-CSF, MIP-1β, and TNFα levels were decreased in HD.
• The promoter of each of these genes contains multiple putative p65/RelA elements.
• CB1 activation restored CCL5 expression in a cell mode of HD via p65/RelA.
• CB1-specific cannabinoids may normalize p65/RelA-dependent gene expression in HD.
Transcriptional dysregulation is a major pathological feature of Huntington's disease (HD). The goal of this study was to understand how p65/RelA co-regulated genes, specifically those of the cytokine and endocannabinoid systems, were affected in HD. p65/RelA levels were lower in human HD tissue and R6/2 HD mice, as were the levels of the type 1 cannabinoid receptor (CB1), IL-1β, IL-8, CCL5, GM-CSF, MIP-1β, and TNFα, all of which may be regulated by p65/RelA. Activation of p65/RelA restored CB1 and CCL5 expression in STHdh cell models of HD. Therefore, p65/RelA activation may normalize the expression of some genes in HD.
Journal: Journal of Neuroimmunology - Volume 267, Issues 1–2, 15 February 2014, Pages 61–72